U.S. based Acasti Pharma to buy Indian origin pharma firm Grace

As per the understanding, Acasti will acquire Grace’s entire therapeutic pipeline consisting of three unique clinical stage and multiple pre-clinical stage assets, according to regulatory filings. The assets are supported by an intellectual property portfolio consisting of more than 40 granted and pending patents in various jurisdictions worldwide.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/33uwx8w
via IFTTT